Theratechnologies Analyst Ratings
Theratechnologies Analyst Ratings
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $0.90, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2023 | 900% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 122.22% | Canaccord Genuity | → $2 | Assumes | → Hold |
| 11/17/2022 | 900% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
| 07/29/2021 | 233.33% | Canaccord Genuity | $8 → $3 | Downgrades | Buy → Hold |
| 04/19/2021 | 788.89% | Canaccord Genuity | $7 → $8 | Maintains | Buy |
| 04/15/2020 | 1122.22% | Canaccord Genuity | $12 → $11 | Maintains | Buy |
| 12/11/2019 | — | Mackie Research | Upgrades | Hold → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/13/2023 | 900% | 坎託·菲茨傑拉德 | → 9 美元 | 重申 | 超重 → 超重 |
| 07/03/2023 | 122.22% | Canaccord Genu | → 2 美元 | 假設 | → 按住 |
| 11/17/2022 | 900% | 坎託·菲茨傑拉德 | → 9 美元 | 啓動覆蓋開啓 | → 超重 |
| 2021 年 7 月 29 日 | 233.33% | Canaccord Genu | 8 美元 → 3 美元 | 降級 | 買入 → 持有 |
| 2021 年 4 月 19 日 | 788.89% | Canaccord Genu | 7 美元 → 8 美元 | 維護 | 購買 |
| 2020 年 4 月 15 日 | 1122.22% | Canaccord Genu | 12 美元 → 11 美元 | 維護 | 購買 |
| 2019 年 11 月 12 日 | — | 麥基研究 | 升級 | 持有 → 買入 |
What is the target price for Theratechnologies (THTX)?
TheraTechnologies (THTX) 的目標價格是多少？
The latest price target for Theratechnologies (NASDAQ: THTX) was reported by Cantor Fitzgerald on July 13, 2023. The analyst firm set a price target for $9.00 expecting THTX to rise to within 12 months (a possible 900.00% upside). 3 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年7月13日公佈了TheraTechnologies（納斯達克股票代碼：THTX）的最新目標股價。這家分析公司將目標股價定爲9.00美元，預計THTX將在12個月內升至900.00％（可能上漲900.00％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Theratechnologies (THTX)?
TheraTechnologies（THTX）的最新分析師評級是多少？
The latest analyst rating for Theratechnologies (NASDAQ: THTX) was provided by Cantor Fitzgerald, and Theratechnologies reiterated their overweight rating.
TheraTechnologies（納斯達克股票代碼：THTX）的最新分析師評級由坎託·菲茨傑拉德提供，TheraTechnologies重申了他們的增持評級。
When is the next analyst rating going to be posted or updated for Theratechnologies (THTX)?
TheraTechnologies（THTX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Theratechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Theratechnologies was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與TheraTechnologies的高管和客戶交談以及聽取財報電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。TheraTechnologies的最後一次評級是在2023年7月13日提交的，因此您應該預計下一個評級將在2024年7月13日左右公佈。
Is the Analyst Rating Theratechnologies (THTX) correct?
分析師對 TheraTechnologies (THTX) 的評級正確嗎
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $0.90, which is within the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的TheraTechnologies（THTX）評級得到了重申，目標股價爲0.00美元至9.00美元。TheraTechnologies（THTX）目前的交易價格爲0.90美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
